SLC5A2 and hydrops fetalis: Our results showed that SGLT2 inhibition was associated with 2.04 (95% CI 0.29, 3.79) SD increase in acylcarnitines score per 1-mmol/L lower genetic RPG via SGLT2 inhibition, and per 1-SD higher score was associated with 3% lower risk of HF (HR (95% CI), 0.97 (0.93, 0.99)).